Topic

UnitedHealthcare (UnitedHealth Group)

A collection of 1322 issues

The Requirements Checklist to Get Revlimid (lenalidomide) Covered by UnitedHealthcare in North Carolina

Answer Box: Getting Revlimid Covered by UnitedHealthcare in North Carolina UnitedHealthcare requires prior authorization for Revlimid (lenalidomide) in North Carolina, with specific criteria for multiple myeloma, MDS, and mantle cell lymphoma. The fastest path: verify REMS enrollment, submit PA via UHC provider portal with diagnosis-specific documentation, and use North Carolina&
5 min read

How to Get Ocrevus (Ocrelizumab) Covered by UnitedHealthcare in California: Renewal Guide, Appeal Scripts, and Timeline

Answer Box: Getting Ocrevus Covered by UnitedHealthcare in California UnitedHealthcare requires prior authorization for Ocrevus (ocrelizumab) with annual renewal documentation showing clinical response. Submit via the UHC Provider Portal with MS diagnosis confirmation, prior DMT trials, and evidence of treatment benefit (stable/improved disability scores, reduced relapses, or MRI stability)
6 min read

How to Get Pombiliti (cipaglucosidase alfa-atga) Covered by UnitedHealthcare in Florida: Complete Prior Authorization and Appeals Guide

Answer Box: To get Pombiliti (cipaglucosidase alfa-atga) covered by UnitedHealthcare in Florida, you'll need prior authorization with documented failure on current ERT (step therapy). Submit via UHCprovider.com or OptumRx forms (fax 844-403-1027). Include late-onset Pompe diagnosis, enzyme/genetic testing, and prior therapy outcomes. If denied, appeal within
5 min read

How to Get Zolgensma (onasemnogene abeparvovec) Covered by UnitedHealthcare in Michigan: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Zolgensma Covered by UnitedHealthcare in Michigan Fastest Path to Approval: UnitedHealthcare requires prior authorization for Zolgensma through their medical benefit policy. You need genetic testing confirming bi-allelic SMN1 mutations, age under 24 months at infusion, anti-AAV9 antibody titer ≤1:50, and treatment at a certified center. If
6 min read

How Long Does It Take to Get Duopa (Carbidopa/Levodopa Enteral) Approved by UnitedHealthcare in Virginia? Complete Timeline & Appeals Guide

Answer Box: Getting Duopa Covered by UnitedHealthcare in Virginia UnitedHealthcare requires prior authorization (PA) for Duopa (carbidopa/levodopa enteral) with 15-day standard review or 72-hour expedited review for urgent cases. Success requires documenting advanced Parkinson's disease, failed oral therapy, and planned PEG-J tube placement. First step: Have your
6 min read

Lowering Out-of-Pocket Costs for Ruconest with UnitedHealthcare in North Carolina: Copay Cards, Appeals & Financial Assistance

Answer Box: Getting Ruconest Covered by UnitedHealthcare in North Carolina UnitedHealthcare requires prior authorization for Ruconest (C1 esterase inhibitor [recombinant]) in North Carolina, with 12-month approvals for confirmed hereditary angioedema (HAE) patients prescribed by allergists/immunologists. The fastest path: 1) Have your HAE specialist submit PA via UHC Provider Portal
6 min read

Lowering Out-of-Pocket Costs for Ilaris (Canakinumab) with UnitedHealthcare in North Carolina: Coverage, Appeals & Financial Assistance

Answer Box: Getting Ilaris Covered by UnitedHealthcare in North Carolina UnitedHealthcare requires prior authorization for Ilaris (canakinumab) under the medical benefit, with step therapy requirements for most indications. Start by having your specialist submit a PA request via the UHC provider portal with complete clinical documentation. If denied, appeal within
6 min read

Myths vs. Facts: Getting Prolastin-C Covered by UnitedHealthcare in Florida (2025 Guide)

Answer Box: Prolastin-C Coverage by UnitedHealthcare in Florida UnitedHealthcare requires prior authorization for Prolastin-C with documented severe alpha-1 antitrypsin deficiency (Pi*ZZ genotype), emphysema evidence, and step therapy trial of preferred alternatives like Aralast NP or Glassia unless contraindicated. Coverage falls under medical benefit with site-of-care preference for home infusion
6 min read